1. 孙倩倩#,郭惠琴*.小细胞肺癌免疫及靶向治疗的相关进展.癌症进展.2022.20(15).1532-1537,1554. |
2. Dan-Dan Shen#, Jing-Ru Pang, Ya-Ping Bi, Long-Fei Zhao, Yin-Rui Li, Li-Juan Zhao, Ya Gao, Bo Wang, Ning Wang, Liuya Wei, Huiqin Guo, Hong-Min Liu*, Yi-Chao Zheng.LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer.Molecular cancer.2022.21(1).75.SCI |
3. Qianqian Sun#,Weiqing Li,Taorui Liu,Huiqin Guo*.Individualized Treatment for Advanced Non-Small Cell Lung Cancer: A Case Report and Literature Review.Frontiers in oncology.2022.12.916681.SCI |
4. Huiqin Guo #, Xin Wang , Weiqing Li , Jianlu Zhang *. An Economical and Available Solution for Surgical Smoke in Video-Assisted Thoracic Surgery.The Annals of thoracic surgery.2022.113(3).e231-e233.SCI |
5. Silpa Narayanana, Chao-Yun Caia, Yehuda G. Assarafb, Hui-Qin Guoc, Qingbin Cuia,d,Liuya Weia,e, Juan-Juan Huangf, Charles R. Ashby Jra,*, Zhe-Sheng Chena,*.Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance.Drug Resistance Updates.2020.48.1-14.SCI |
6. Lin, X., Xiao, Z., Chen, T., Liang, S. H., & Guo, H. . Glucose Metabolism on Tumor Plasticity, Diagnosis, and Treatment.Frontiers in oncology.2020.10.1-10.SCI |
7. Zhi Shi 1*, Hui-Qin Guo 2, Pascale A. Cohen 3 and Dong-Hua Yang 4*.Novel Targets and Biomarkers in Solid Tumors.Front Pharmacol.2019.10.1-2.SCI |
8. Feng Guo,Zhili Cao,Huiqin Guo*.The action mechanism of lncRNA-HOTAIR on the drug resistance of non-small cell lung cancer by regulating Wnt signaling pathway. p4885-4889.EXPERIMENTAL AND THERAPEUTIC MEDICINE.2018.15(6).4885-4889.SCI |
9. Huiqin Guo1# and Kangla Tsung*.Tumor reductive therapies and antitumor immunity. Oncotarget,Oncotarget 2017. 8(33) p. 55736-55749.Oncotarget.2017.Vol. 8, (No. 33).55736-55749.SCI |
10. Zhang, Y.#, Guo H., et al.*.NOTCH1 Signaling Regulates Self-Renewal and Platinum Chemoresistance of Cancer Stem-like Cells in Human Non-Small Cell Lung Cancer. Cancer Res.Published OnlineFirst 2017. 77(11)p. 3082-3091.Cancer Research.2017.77(11) June 1.3082-3091.SCI |
11. 姜博伦# 赵晨光 郭惠琴* .PD-1/PD-L1抑制剂及其疗效预测标志物在非小细胞肺癌中的研究进展更新.癌症进展.2017.15(12).1369-1374. |
12. 丁程# 姜博伦 赵晨光 郭惠琴*.非小细胞肺癌脑转移的研究进展.癌症进展.2017.15(4).367-370. |
13. Tian, G., Guo H., et al.,*.Protective effect of Flt3L on organ structure during advanced multiorgan dysfunction syndrome in mice. Mol Med Rep,p. 4135-41..MOLECULAR MEDICINE REPORTS.2015.11(6).4135-41.SCI |
14. Zhang, G.N., Guo H., et al.*.The reversal of antineoplastic drug resistance in cancer cells by beta-elemene. Chin J Cancer,p. 488-95.Chinese Journal of Cancer .2015.34(11).488-95.SCI |
15. Anreddy, N., Guo H., et al.*.A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo. Oncotarget.p. 39276-91.Oncotarget.2015.6(36).39276-91.SCI |